Ameriprise Financial Inc Spero Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.47 $60,678 - $89,196	-60,678 Reduced 13.09%	402,963 $592,000
Q3 2023 Nov 14, 2023	SELL	$1.2 - $1.63 $5,182 - $7,039	-4,319 Reduced 0.92%	463,641 $561,000
Q2 2023 Aug 14, 2023	BUY	$1.42 - $1.95 $664,503 - $912,522	467,960 New	467,960 $678,000
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $434,115 - $4.36 Million	-586,642 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.87 - $15.15 $1.76 Million - $3.38 Million	223,108 Added 61.37%	586,642 $5.1 Million
Q4 2021 Feb 14, 2022	SELL	$13.09 - $18.77 $177,513 - $254,539	-13,561 Reduced 3.6%	363,534 $5.82 Million
Q3 2021 Nov 15, 2021	SELL	$13.03 - $19.51 $804,498 - $1.2 Million	-61,742 Reduced 14.07%	377,095 $6.94 Million
Q2 2021 Aug 16, 2021	BUY	$12.22 - $15.79 $49,478 - $63,933	4,049 Added 0.93%	438,837 $6.13 Million
Q1 2021 May 17, 2021	BUY	$13.23 - $21.48 $2.24 Million - $3.64 Million	169,347 Added 63.8%	434,788 $6.4 Million
Q4 2020 Feb 12, 2021	BUY	$11.65 - $22.07 $3.09 Million - $5.86 Million	265,441 New	265,441 $5.15 Million
Q3 2020 Nov 16, 2020	SELL	$8.96 - $14.12 $192,227 - $302,930	-21,454 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.27 - $14.18 $155,970 - $304,217	21,454 New	21,454 $290,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $41.4M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.